ConclusionThe CARRA Registry has enrolled a large, racially and ethnically diverse cohort of cSLE patients that are early in their disease course, exhibit moderate disease activity and have minimal damage scores. The use of hydroxychloroquine in this cohort is high; hydroxychloroquine use at enrollment was a strong predictor of LLDAS attainment. This cohort provides a unique opportunity to study longitudinally the impact of disease activity and immunosuppressive medications in a young SLE cohort.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.